跳至主要内容
临床试验/CTRI/2020/01/023027
CTRI/2020/01/023027已完成2 期

A DOUBLE BLIND RANDOMISED PLACEBO CONTROLLED EVALUATATION OF ADJUVANT EFFECT OF KIMSHUKATVAGADI GHANA CAPSULE IN PRAMEHA WITH SPECIAL REFRENCE TO DIABETES MELLITUS TYPE II

Dean Faculty of Ayurved Parul University0 个研究点目标入组 67 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
67

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Known cases of Diabetes Mellitus Type II and on medication showing symptoms of Prameha.
  • 2) Patients with FBS 125mg/dl to 300 mg/dl and PPBS 140 mg/dl to 400 mg/dl (both inclusive)
  • 3) Patients with HbA1C levels between 7.0 - 9.5 mg%

排除标准

  • 1) Patients having FBS more than 300mg/dl
  • PP2BS more than 400mg/dl
  • HbA1C more than 9.5mg%
  • 2) Patients showing acute complications and chronic complications - neuropathy, nephropathy, retinopathy.
  • 3) Patients with Diabetes Mellitus Type I
  • 4) Lactating and Pregnant Women
  • 5) Patients with other systemic diseases - IHD, uncontrolled hypertension.

研究者

发起方
Dean Faculty of Ayurved Parul University

相似试验